Search results

1. ASCO 2025 preview – Itovebi strengthens its first-line claim

   ASCO 2025 preview – Itovebi strengthens its first-line … *recalculated from 15.0 months. Source: product labels & ASCO 2025.   Both drugs hit the wild-type and mutant …

   
    

   Madeleine Armstrong
    
   - 05/27/2025 - 14:58

2. AbbVie gets a cMet niche

   … in high cMet expressers at doses ≥2.4mg/kg); data due at ASCO 2025 in EGFRm non-sq NSCLC Notes: …

   
    

   Madeleine Armstrong
    
   - 05/19/2025 - 10:52

3. ASCO 2025 preview – late-breakers in focus

   ASCO 2025 preview – late-breakers in focus … the morning of their presentations.   Selected ASCO 2025 late-breakers Project Company/ies …

   
    

   Jacob Plieth
    
   - 04/28/2025 - 14:08